インフルエンザワクチンの世界市場

• 英文タイトル:Global Market Study on Flu Vaccines: Alleviating the Stress on Healthcare Systems amid COVID-19 Pandemic

Global Market Study on Flu Vaccines: Alleviating the Stress on Healthcare Systems amid COVID-19 Pandemic「インフルエンザワクチンの世界市場」(市場規模、市場予測)調査レポートです。• レポートコード:PMR2008044
• 出版社/出版日:Persistence Market Research / 2020年5月13日
• レポート形態:英文、PDF、195ページ
• 納品方法:Eメール
• 産業分類:生命科学
• 販売価格(消費税別)
  Individual User(1名用)¥558,600 (USD4,900)▷ お問い合わせ
  Multi User(5名用)¥866,400 (USD7,600)▷ お問い合わせ
  Corporate User(企業用)¥1,208,400 (USD10,600)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、インフルエンザワクチンの世界市場について調査・分析し、エグゼクティブサマリー、市場概要、主要市場動向、需要分析・予測、市場背景、製品種類別(三価インフルエンザワクチン、四価インフルエンザワクチン)分析、剤形別(筋肉内注射、鼻スプレー、皮内注射)分析、流通チャネル別(機関、小売り)分析、地域別分析、市場構造分析、競争分析、仮定、調査手法などを含め、以下の構成でお届けいたします。
・エグゼクティブサマリー
・市場概要
・主要市場動向
・需要分析・予測
・市場背景
・インフルエンザワクチンの世界市場規模:製品種類別(三価インフルエンザワクチン、四価インフルエンザワクチン)
・インフルエンザワクチンの世界市場規模:剤形別(筋肉内注射、鼻スプレー、皮内注射)
・インフルエンザワクチンの世界市場規模:流通チャネル別(機関、小売り)
・インフルエンザワクチンの世界市場規模:地域別
・市場構造分析
・競争分析
・仮定
・調査手法

Flu Vaccine Market – Analysis and Opportunity Assessment

Persistence Market Insights (PMR), in its new publication, outlines the growth trails of ‘Flu Vaccine Market’ for the period between 2020 and 2030. The study includes a thorough analysis of historical and current trends that can impact the future development of flu vaccine market. It offers various drivers, restrains, challenges, and opportunities in the flu vaccine market. The report brings to fore actionable insights on nodes and internodes of the flu vaccine market that can arm the vendors with necessary information to take critical decision with confidence.

PMR’s study covers a key indicator assessment to estimate the growth prospects of the flu vaccine market during the predefined period, along with forecast statistics in terms of value (US$ million). In addition, the report consists of multiple sections explaining the global healthcare spending outlook and awareness about flu and flu vaccination.

Readers can find a detailed taxonomy in the report, along with an incisive outlook on the competitive landscape in flu vaccine market. The study profiles a number of incumbent companies and new entrants in the flu market, wherein, product portfolio, new launches, technological innovations, and dynamic growth strategies of these players have been detailed.

What are the Key Questions Answered in the Flu Vaccine Market Report?

PMR’s study assesses the flu vaccine market at both macroscopic and microscopic levels to offer detailed insights that can help determine sustained opportunities for the stakeholders. Exclusive information provided in the flu vaccine market report addresses various important questions required to understand and gain comprehensive knowledge about the market. Some of these questions are:

How is regulatory framework in different nations affecting the growth of flu vaccine market?
How has the flu vaccine market performed so far and how will it perform in the next decade?
What are winning strategies of key players in the flu vaccine market?
What are the opportunities market stakeholders are eyeing to strengthen their position in the global market?
What are development risks and competitive threats faced by the flu vaccine market players across different regions?
Research Methodology

The research methodology followed for obtaining complete information regarding the developments in flu vaccine market involves conducting an in-depth market research with the help of various primary and secondary resources. By analyzing the information gathered through and verified by these resources, analysts could offer exclusive insights on how the flu vaccine market will grow and expand during the predefined period.

Analysts have conducted interviews and discussion with healthcare consultants, CEOs, KOLs, regional officers, and sales managers of companies in the supply chain of flu vaccine drugs. The data obtained through these discussions have contributed to the development of the flu vaccine market report as a primary resource.

Secondary resources referred by the analysts for the compilation of flu vaccine market report include company annual and financial reports_bk_01_01_2020, white papers, industrial association publications, research publications, and leading industry magazines. Other secondary resources are Global Alliance of Vaccine and Immunization (Gavi), International Society of Vaccines, and IFPMA.

レポート目次

1. Executive Summary

1.1. Global Market Outlook

1.2. Recent Developments

1.3. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Key Market Trends

3.1. Key Trends Impacting the Market

4. Global Flu Vaccines Market Demand (in Value or Size in US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030

4.1. Historical Market Value (US$ Mn) Analysis, 2015-2019

4.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030

4.2.1. Y-o-Y Growth Trend Analysis

4.2.2. Absolute $ Opportunity Analysis

5. Market Background

5.1. Macro-Economic Factors

5.1.1. Global Healthcare Spending Outlook

5.2. Forecast Factors – Relevance & Impact

5.2.1. Vaccination Rate

5.2.2. Awareness about Flu and Flu Vaccination

5.2.3. Availability of Flu Vaccines

5.2.4. Demand for Flu Vaccines in Different Countries

5.2.5. Collaboration among manufacturers

5.3. Market Dynamics

5.3.1. Drivers

5.3.2. Restraints

5.3.3. Opportunity Analysis

6. Global Flu Vaccines Market Analysis 2015-2019 and Forecast 2020-2030, by Product Type

6.1. Introduction / Key Findings

6.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2015-2019

6.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2020-2030

6.3.1. Trivalent Flu Vaccines

6.3.2. Quadrivalent Flu Vaccines

6.4. Market Attractiveness Analysis By Product Type

7. Global Flu Vaccines Market Analysis 2015-2019 and Forecast 2020-2030, by Dosage Form

7.1. Introduction / Key Findings

7.2. Historical Market Size (US$ Mn) Analysis By Dosage Form, 2015-2019

7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Dosage Form, 2020-2030

7.3.1. Intramuscular Injection

7.3.2. Nasal Spray

7.3.3. Intradermal Shot

7.4. Market Attractiveness Analysis By Dosage Form

8. Global Flu Vaccines Market Analysis 2015-2019 and Forecast 2020-2030, by Distribution Channel

8.1. Introduction / Key Findings

8.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2015-2019

8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2020-2030

8.3.1. Institutional Sales

8.3.1.1. Hospitals

8.3.1.2. Community Clinics

8.3.1.3. Public Health Agencies

8.3.1.4. Workplace Purchasing

8.3.2. Retail Sales

8.3.2.1. Retail Pharmacy

8.3.2.2. Mail Order Pharmacy

8.4. Market Attractiveness Analysis By Distribution Channel

9. Global Flu Vaccines Market Analysis 2015-2019 and Forecast 2020-2030, by Region

9.1. Introduction

9.2. Historical Market Size (US$ Mn) and Volume Analysis By Region, 2015-2019

9.3. Current Market Size (US$ Mn) and Volume Analysis and Forecast By Region, 2020-2030

9.3.1. North America

9.3.2. Latin America

9.3.3. Europe

9.3.4. South Asia

9.3.5. East Asia

9.3.6. Oceania

9.3.7. Middle East and Africa (MEA)

9.4. Market Attractiveness Analysis By Region

10. North America Flu Vaccines Market Analysis 2015-2019 and Forecast 2020-2030

10.1. Introduction

10.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2015-2019

10.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2020-2030

10.3.1. By Country

10.3.1.1. U.S.

10.3.1.2. Canada

10.3.2. By Product Type

10.3.3. By Dosage Form

10.3.4. By Distribution Channel

10.4. Market Attractiveness Analysis

10.5. Drivers and Restraints – Impact Analysis

11. Latin America Flu Vaccines Market Analysis 2015-2019 and Forecast 2020-2030

11.1. Introduction

11.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2015-2019

11.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2020-2030

11.3.1. By Country

11.3.1.1. Brazil

11.3.1.2. Mexico

11.3.1.3. Rest of Latin America

11.3.2. By Product Type

11.3.3. By Dosage Form

11.3.4. By Distribution Channel

11.4. Market Attractiveness Analysis

11.5. Drivers and Restraints – Impact Analysis

12. Europe Flu Vaccines Market Analysis 2015-2019 and Forecast 2020-2030

12.1. Introduction

12.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2015-2019

12.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2020-2030

12.3.1. By Country

12.3.1.1. Germany

12.3.1.2. Italy

12.3.1.3. France

12.3.1.4. U.K.

12.3.1.5. Spain

12.3.1.6. BENELUX

12.3.1.7. Russia

12.3.1.8. Rest of Europe

12.3.2. By Product Type

12.3.3. By Dosage Form

12.3.4. By Distribution Channel

12.4. Market Attractiveness Analysis

12.5. Drivers and Restraints – Impact Analysis

13. South Asia Flu Vaccines Market Analysis 2015-2019 and Forecast 2020-2030

13.1. Introduction

13.2. Pricing Analysis

13.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2015-2019

13.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2020-2030

13.4.1. By Country

13.4.1.1. India

13.4.1.2. Thailand

13.4.1.3. Indonesia

13.4.1.4. Malaysia

13.4.1.5. Rest of South Asia

13.4.2. By Product Type

13.4.3. By Dosage Form

13.4.4. By Distribution Channel

13.5. Market Attractiveness Analysis

13.6. Drivers and Restraints – Impact Analysis

14. East Asia Flu Vaccines Market Analysis 2015-2019 and Forecast 2020-2030

14.1. Introduction

14.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2015-2019

14.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2020-2030

14.3.1. By Country

14.3.1.1. China

14.3.1.2. Japan

14.3.1.3. South Korea

14.3.2. By Product Type

14.3.3. By Dosage Form

14.3.4. By Distribution Channel

14.4. Market Attractiveness Analysis

14.5. Drivers and Restraints – Impact Analysis

15. Oceania Flu Vaccines Market Analysis 2015-2019 and Forecast 2020-2030

15.1. Introduction

15.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2015-2019

15.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2020-2030

15.3.1. By Country

15.3.1.1. Australia

15.3.1.2. New Zealand

15.3.2. By Product Type

15.3.3. By Dosage Form

15.3.4. By Distribution Channel

15.4. Market Attractiveness Analysis

15.5. Drivers and Restraints – Impact Analysis

16. Middle East and Africa Flu Vaccines Market Analysis 2015-2019 and Forecast 2020-2030

16.1. Introduction

16.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2015-2019

16.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2020-2030

16.3.1. By Country

16.3.1.1. GCC Countries

16.3.1.2. Turkey

16.3.1.3. Northern Africa

16.3.1.4. South Africa

16.3.1.5. Rest of Middle East and Africa

16.3.2. By Product Type

16.3.3. By Dosage Form

16.3.4. By Distribution Channel

16.4. Market Attractiveness Analysis

16.5. Drivers and Restraints – Impact Analysis

17. Market Structure Analysis

17.1. Market Analysis by Tier of Companies (Flu Vaccines)

17.2. Market Share Analysis of Top Players

17.3. Market Presence Analysis

17.3.1. By Regional footprint of Players

17.3.2. Product foot print by Players

17.3.3. Channel Foot Print by Players

18. Competition Analysis

18.1. Competition Dashboard

18.2. Competition Benchmarking

18.3. Competition Deep Dive

18.3.1. Sanofi Pasteur Inc. (Sanofi S/A)

18.3.1.1. Overview

18.3.1.2. Product Portfolio

18.3.1.3. Profitability by Market Segments (Product/Channel/Region)

18.3.1.4. Sales Footprint

18.3.1.5. Strategy Overview

18.3.1.5.1. Marketing Strategy

18.3.1.5.2. Product Strategy

18.3.1.5.3. Channel Strategy

18.3.2. AstraZeneca

18.3.2.1. Overview

18.3.2.2. Product Portfolio

18.3.2.3. Profitability by Market Segments (Product/Channel/Region)

18.3.2.4. Sales Footprint

18.3.2.5. Strategy Overview

18.3.2.5.1. Marketing Strategy

18.3.2.5.2. Product Strategy

18.3.2.5.3. Channel Strategy

18.3.3. CSL Ltd. (Seqirus)

18.3.3.1. Overview

18.3.3.2. Product Portfolio

18.3.3.3. Profitability by Market Segments (Product/Channel/Region)

18.3.3.4. Sales Footprint

18.3.3.5. Strategy Overview

18.3.3.5.1. Marketing Strategy

18.3.3.5.2. Product Strategy

18.3.3.5.3. Channel Strategy

18.3.4. Abbott

18.3.4.1. Overview

18.3.4.2. Product Portfolio

18.3.4.3. Profitability by Market Segments (Product/Channel/Region)

18.3.4.4. Sales Footprint

18.3.4.5. Strategy Overview

18.3.4.5.1. Marketing Strategy

18.3.4.5.2. Product Strategy

18.3.4.5.3. Channel Strategy

18.3.5. GlaxoSmithKline Plc.

18.3.5.1. Overview

18.3.5.2. Product Portfolio

18.3.5.3. Profitability by Market Segments (Product/Channel/Region)

18.3.5.4. Sales Footprint

18.3.5.5. Strategy Overview

18.3.5.5.1. Marketing Strategy

18.3.5.5.2. Product Strategy

18.3.5.5.3. Channel Strategy

18.3.6. Serum Institute of India Pvt. Ltd.

18.3.6.1. Overview

18.3.6.2. Product Portfolio

18.3.6.3. Profitability by Market Segments (Product/Channel/Region)

18.3.6.4. Sales Footprint

18.3.6.5. Strategy Overview

18.3.6.5.1. Marketing Strategy

18.3.6.5.2. Product Strategy

18.3.6.5.3. Channel Strategy

19. Research Methodology

List of Tables

Table 01: Global Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 02: Global Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Dosage Form

Table 03: Global Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel

Table 04: Global Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Region

Table 05: North America Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country

Table 06: North America Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 07: North America Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Dosage Form

Table 08: North America Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel

Table 09: Latin America Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country

Table 10: Latin America Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 11: Latin America Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Dosage Form

Table 12: Latin America Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel

Table 13: Europe Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country

Table 14: Europe Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 15: Europe Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Dosage Form

Table 16: Europe Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel

Table 17: South Asia Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country

Table 18: South Asia Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 19: South Asia Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Dosage Form

Table 20: South Asia Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel

Table 21: East Asia Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country

Table 22: East Asia Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 23: East Asia Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Dosage Form

Table 24: East Asia Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel

Table 25: Oceania Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country

Table 26: Oceania Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 27: Oceania Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Dosage Form

Table 28: Oceania Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel

Table 29: MEA Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country

Table 30: MEA Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 31: MEA Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Dosage Form

Table 32: MEA Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel

Table 33: China Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 34: China Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Dosage Form

Table 35: China Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel

Table 36: India Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 37: India Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Dosage Form

Table 38: India Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel

Table 39: Brazil Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 40: Brazil Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Dosage Form

Table 41: Brazil Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel


• 英文レポート名:Global Market Study on Flu Vaccines: Alleviating the Stress on Healthcare Systems amid COVID-19 Pandemic
• 日本語訳:インフルエンザワクチンの世界市場
• レポートコード:PMR2008044お問い合わせ(見積依頼・ご注文・質問)